Hearing-loss drugmaker Sound Pharmaceuticals posts strong clinical results, eyes a $100M IPO by James Thorne on July 12, 2019July 15, 2019 at 7:46 am Sound Pharmaceuticals, a Seattle-based drugmaker that is creating a first-of-its-kind treatment for hearing loss, recently reported encouraging top-line results from a Phase II clinical trial and is eyeing a potential… Read More